The Big Event: Humira Biosimilar Launches
Introduction Today is the day! The Big Event of 2023 is the launch of multiple Humira biosimilars [...]
Biosimilars: The Coming Wave
Introduction There is a big wave of changes coming to the pharmacy market. The extent of the [...]
Paying the Piper: How 2020 Could Make 2023 Even Tougher for Value-Based Care Providers
It’s widely predicted that 2023 will pose broad economic challenges. Reasons abound for a potential recession, but in [...]
Biosimilars: A Brief Introduction
The coming market introduction of several significant biosimilars is predicted to bring a wave of change to [...]
Plan Design Survey of the 2023 Individual Market
The macroeconomic environment is radically shifting as inflation ratchets up costs in every consumer category, including health care. [...]
Intelligent Capitation Rates – Strategically Aligning Risk Adjustment with Costs
Introduction Aligning capitation rates with the line of business and risk selection of attributed members is an [...]
Time to Talk About Trend
There have been a number of market-changing dynamics over the last few years affecting healthcare with COVID [...]
My Recent Experience with Kaiser Health System
I moved from the east coast to the west coast seven years ago. My employer had several options [...]
Utilization Profiling for Care Management (and Profitability!)
Although there are many variables influencing healthcare costs, the most important are unit cost and utilization. Unit cost [...]
Pharmacy Provisions of the Inflation Reduction Act
Introduction I read the 725-page draft of the Deficit Reduction Act[1] so you don’t have to. Well, [...]